← Leaderboards
Guo-Hua Chu
Venatorx Pharmaceuticals, Inc.
$599,200
Attributed
$599,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $299.6K · FY2014–15$500K$375K$250K$125K$0
'14
'15
Funding mix
By agency
NIH$599,200 · 1
By mechanism
R43$599,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Venatorx Pharmaceuticals, Inc.
Same institution · by research overlap
- Luigi Xerri$39,662,982
- Steven Armen Boyd$13,685,544
- Denis Marc Daigle$7,512,530
- Bin Liu$3,147,000
- Tsuyoshi Uehara$2,000,000
Others in their field
Top investigators on “Amoxicillin-Potassium Clavulanate Combination”
- Mary F. Morrison · Temple Univ Of The Commonwealth$5,117,685
- Luigi Xerri · Venatorx Pharmaceuticals, Inc.$5,040,618
- Christopher John Burns · Protez Pharmaceuticals, Inc.$3,040,618
- Bo Li · Harvard Medical School$2,332,500
- Christina Chambers · Rady Pediatric Genomics & Systems Medicine Institute$1,687,490
- Robert J Fontana · University Of Michigan At Ann Arbor$1,683,495
Research focus
Amoxicillin-Potassium Clavulanate CombinationAwardBacterial InfectionsBaseBeta-LactamaseBioavailableBiological AvailabilityCanis FamiliarisCefiximeCephalosporinsChemistryCitrobacterClavulanateCombined Modality TherapyCommunicable DiseasesCommunitiesCommunity SettingCostData CorrelationsEconomic ImpactEnterobacteriaceaeEnzymesEquationAmoxicillin